Trosolwyg
Rwy'n Dechnegydd Ymchwil yn yr Adran Canser a Geneteg yn yr Ysgol Meddygaeth
Rwy'n gyfrifol am samplau cleifion sy'n dod i dreialon clinigol AML (Lewcemia Myeloid Acíwt), a ariennir gan ECMC
Mae gen i bortffolio eang o brofiad ymchwil ar ôl gweithio mewn R a Datblygu mewn sefydliadau Diwydiant ac Academaidd.
Cyhoeddiad
2020
- Alanazi, B. et al. 2020. Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia. Leukemia 34(2), pp. 427-440. (10.1038/s41375-019-0596-4)
2012
- Forrest, M., Chapman, R. M., Doyle, A. M., Tinsley, C. L., Waite, A. J. and Blake, D. J. 2012. Functional analysis of TCF4 missense mutations that cause Pitt-Hopkins syndrome. Human Mutation 33(12), pp. 1676-1686. (10.1002/humu.22160)
Erthyglau
- Alanazi, B. et al. 2020. Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia. Leukemia 34(2), pp. 427-440. (10.1038/s41375-019-0596-4)
- Forrest, M., Chapman, R. M., Doyle, A. M., Tinsley, C. L., Waite, A. J. and Blake, D. J. 2012. Functional analysis of TCF4 missense mutations that cause Pitt-Hopkins syndrome. Human Mutation 33(12), pp. 1676-1686. (10.1002/humu.22160)